Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation.
Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation.
复制标题
酰胺类局麻药可能通过上调 RASSF1A 表达和去甲基化来抑制肿瘤细胞增殖并使人肝细胞癌细胞对顺铂敏感
DOI:
10.7150/jca.46630
复制
发表时间:
2020
影响因子:
3.9
通讯作者:
Xing W
中科院分区:
文献类型:
--
作者:
Chen D;Yan Y;Xie J;Pan J;Chen Y;Li Q;Yuan Y;Zeng W;Xing W
Background: It has been reported that local anesthetics are toxic to various types of cells. Furthermore, several local anesthetics have been confirmed to exert demethylation effects and regulate the proliferation of human cancer cells. Our previous findings suggest that lidocaine may exert potential antitumor activity and enhance the sensitivity of cisplatin to hepatocellular carcinoma in vitro and in vivo. A recent study proved that lidocaine sensitizes breast cancer cells to cisplatin via upregulation of RASSF1A, a promotor of tumor suppressive gene (TSG) demethylation. We sought to determine whether amide-type local anesthetics (lidocaine, ropivacaine and bupivacaine) exert growth-inhibitory effects on human hepatoma cells and to determine whether amide-type local anesthetics sensitize human hepatoma cells to cisplatin-mediated cytotoxicity via upregulation of RASSF1A expression. Methods: Human hepatoma cell lines HepG2 and BEL-7402 were incubated with lidocaine, ropivacaine and bupivacaine. The viability of local anesthetic-treated cells with or without cisplatin was investigated. Further, we evaluated RASSF1A expression after treatment of HepG2 and BEL-7402 cells with three local anesthetics and determined the influence of RASSF1A expression on the toxicity of cisplatin to these cells. Results: The viability of HepG2 and BEL-7402 cells was significantly decreased by treatment with amide-type local anesthetics (lidocaine, ropivacaine and bupivacaine). In these cells, the combination treatment with cisplatin and local anesthetics exhibited a stronger reduction in viability. Lidocaine, ropivacaine and bupivacaine promoted a significant increase in RASSF1A expression and a decrease in RASSF1A methylation. The combined treatment with both local anesthetics and cisplatin resulted in a significantly lower level of HepG2 and BEL-7402 cell viability than that with singular local anesthetics or cisplatin treatment. Moreover, local anesthetics enhanced the cytotoxicity of cisplatin against HepG2 and BEL-7402 cells, accompanied by an increase in RASSF1A expression. Conclusions: These data indicated that amide-type local anesthetics (lidocaine, ropivacaine and bupivacaine) have growth-inhibitory and demethylation effects in human hepatoma cells. We also found that these amide local anesthetics may enhance the cytotoxicity of cisplatin in human hepatocellular carcinoma cells possibly via upregulation of RASSF1A expression and demethylation.
登录
查看更多内容
DOI:
10.1158/1940-6207.capr-13-0067
发表时间:
2013-04
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
Schneider BG;Peek RM Jr
通讯作者:
Peek RM Jr
影响因子:
5.7
作者:
Sakaguchi, M;Kuroda, Y;Hirose, M
通讯作者:
Hirose, M
影响因子:
15.9
作者:
Levesley, Jane;Lusher, Meryl E.;Coyle, Beth
通讯作者:
Coyle, Beth
影响因子:
7.5
作者:
Liu, Juan;Xie, Yi-Shan;Luo, He-Sheng
通讯作者:
Luo, He-Sheng
影响因子:
30.8
作者:
Costello, JF;Fr端hwald, MC;Plass, C
通讯作者:
Plass, C